Verified employee & interview reviews

Edwards Lifesciences India Reviews

Bengaluru, Karnataka

4.0/ 5

1 review

Edwards Lifesciences India Private Limited, established in India on August 29, 1996, is a key subsidiary of Edwards Lifesciences Corporation, a global medical technology leader based in Irvine, California. Specializing in innovations for structural heart disease, critical care, and surgical monitoring, the company serves patients suffering from advanced cardiovascular illnesses. As a private unlisted entity registered with the Registrar of Companies (RoC) in Mumbai, Maharashtra, it has spent nearly three decades building a prominent footprint in India's healthcare landscape, operating within the manufacture of medical, precision, surgical, and optical instruments. The company's primary corporate and registered office is situated at the 4th Floor, Commerz II, International Business Park, Oberoi Garden City, Off Western Express Highway, Goregaon (East), Mumbai. Structurally, the firm operates with an authorized share capital of INR 18.5 crore and a paid-up capital of INR 18.4 crore. For the fiscal year ending March 31, 2025, Edwards Lifesciences India generated an annual revenue of INR 224 crore, showcasing a compounded annual growth rate (CAGR) of 9% over the previous fiscal period, alongside a net profit margin increase of 4.26%. As of 2025, the local operations are driven by a dedicated workforce of approximately 80 employees, managed under a corporate leadership structure that has historically included directors such as Parameswaran Nair and Daniel James Lippis. Edwards India is highly regarded for bringing global, patient-focused medical innovations to the domestic market. Its core product portfolio centers around advanced tissue heart valves, transcatheter aortic valve replacements (TAVR) like the SAPIEN family, transcatheter mitral and tricuspid therapies, and implantable heart failure management solutions. These medical devices cater to critical unmet needs in India, where cardiovascular conditions represent a primary cause of mortality. In alignment with public health initiatives, the company actively supports the Government of India’s National Programme for Prevention & Control of Cancer, Diabetes, Cardiovascular Disease and Stroke (NPCDCS), expanding localized awareness, early screening, and clinical diagnostic accessibility. Internally, the organization places a heavy emphasis on an progressive corporate culture focused on diversity, inclusivity, and holistic employee wellness. The business allows for flexible remote work frameworks and provides detailed mental, physical, and financial health programs for its staff. Notably, it champions the advancement of female professionals through localized resource initiatives like the Edwards Network of Women (ENOW). Because of these ongoing internal practices, Edwards India has received industry recognitions as a premier workplace within the domestic healthcare sector and a preferred organization for women. Through strategic distribution, collaborations with premium clinicians, and dedicated philanthropic outreaches, the company remains focused on treating underserved structural heart populations across India, Sri Lanka, Nepal, and Bangladesh.